## Abstract A twoβstage design is proposed to choose among several experimental treatments and a standard treatment in clinical trials. The first stage employs a selection procedure to select the best treatment, provided it is better than the standard. The second stage tests the hypothesis between
A Bayesian adaptive design for two-stage clinical trials with survival data
β Scribed by Uttam Bandyopadhyay; Atanu Biswas; Rahul Bhattacharya
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 336 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1380-7870
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Health care utilization and outcome studies call for hierarchical approaches. The objectives were to predict major complications following percutaneous coronary interventions by health providers, and to compare Bayesian and nonβBayesian sample size calculation methods. The hierarchical
Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this
We developed an interactive and menu-driven computer program to help investigators design and analyze phase II cancer clinical trials with a group sequential method, namely the sequential probability ratio test or the triangular test. Based on the values selected for the parameters of the trial, the